C
Corona Remedies Limited IPO
⚫ ListedNSE + BSEMainboard IPOHealthcare
Issue Price
₹1009–1062
Issue Size
₹3840 Cr
Lot Size
14 shares
Min. Invest
₹15K
Open Date
11 Feb 2026
Close Date
13 Feb 2026
Allotment
14 Feb 2026
Listing Date
18 Feb 2026
84
IPOGenie Score
Subscribe
out of 100
Grey Market Premium
+₹340
+32.01% above issue price
Est. Listing₹1402
GMP is unofficial — not regulated by SEBI.
Listing Performance
+38.42%
Listed at ₹1470
Current: ₹1510
IPOGenie Score — Corona Remedies Limited
Our 5-factor scoring model: Financial Quality (30) + Subscription (25) + GMP (20) + Business (15) + Risk (10). Total: 84/100 — Subscribe.
Financial Quality23/30
Subscription Momentum25/25
GMP Sentiment20/20
Business Quality8/15
Risk Assessment8/10
This score is an analytical tool only, not investment advice. Consult a SEBI-registered advisor.
IPOGenie Market Signal🟢 Bullish
Strong QIB demand (298.1×) + GMP ₹340 (+32.0%) → Bullish outlook. Score 84/100.
IPOGenie Review — Corona Remedies Limited
Chronic therapy focused branded generics. 3 WHO-GMP plants in Gujarat. 3,000+ stockists, 100K+ retail pharmacies, 15K+ doctors. Exports to 20+ countries.
The star IPO of Q1 2026. Listed 38.42% above issue price (Rs 1,470 vs Rs 1,062). Now at Rs 1,510. 148x oversubscribed. Chronic therapy portfolio has loyal patients — doctors and patients rarely switch BP/diabetes brands. Hold for long-term.
Strengths
- 38.42% listing gain — standout IPO of 2026
- Chronic therapy: loyal patients, sticky prescriptions
- Strong brand recall with Tier 2-3 city doctors
- 3 WHO-GMP plants
Risks
- High OFS Rs 2,640 crore — promoters taking money out
- NPPA pricing pressure on pharmaceutical margins
- Competition from Sun Pharma, Cipla, Dr Reddy
Corona Remedies Limited IPO — Complete Details
| Open Date | 11 February 2026 |
| Close Date | 13 February 2026 |
| Allotment Date | 14 February 2026 |
| Listing Date | 18 February 2026 |
| Price Band | ₹1009 – ₹1062 per share |
| Face Value | ₹10 per share |
| Lot Size | 14 shares |
| Min. Investment (Retail) | ₹14,868 |
| Issue Size | ₹3840 Crores |
| Fresh Issue | ₹1200 Crores |
| Offer for Sale (OFS) | ₹2640 Crores |
| Listing Exchange | NSE, BSE |
| IPO Type | Mainboard IPO (NSE + BSE) |
| Issue Type | Book Built |
| Registrar | Link Intime India Pvt Ltd |
| Lead Manager(s) | JM Financial Ltd, IIFL Securities Ltd, SBI Capital Markets Ltd |
| Anchor Allocation | ₹1152 Crores |
| Promoter Holding (Pre-IPO) | 62.8% |
Corona Remedies Limited — Financial Snapshot
Revenue
₹1840 Cr
Net Profit (PAT)
₹280 Cr
EPS (Diluted)
₹38.2
P/E (Post-Issue)
27.8x
ROE
22.4%
ROCE
26.8%
Market Cap
N/A
Sector
Healthcare
Use of IPO Proceeds
- 1Debt repayment: Rs 500 crore
- 2R&D: Rs 300 crore
- 3Working capital: Rs 400 crore
- 4OFS to selling shareholders
IPO Documents
⚠️ Always read the RHP before investing — it contains all material risk factors and financial disclosures.
Frequently Asked Questions — Corona Remedies Limited IPO
When does Corona Remedies Limited IPO open and close?
Corona Remedies Limited IPO opens on 11 February 2026 and closes on 13 February 2026. Allotment is expected on 14 February 2026 and listing on 18 February 2026.
What is the price band and lot size of Corona Remedies Limited IPO?
Corona Remedies Limited IPO price band is ₹1009–₹1062 per share. Lot size is 14 shares. Minimum investment for retail investors is ₹14,868 (1 lot at cut-off price).
What is the GMP of Corona Remedies Limited IPO today?
Corona Remedies Limited IPO GMP (Grey Market Premium) today is ₹340 (+32.01%), suggesting an estimated listing price of ₹1402. GMP is unofficial and not regulated by SEBI — use it as a sentiment indicator only.
How to check Corona Remedies Limited IPO allotment status?
Check Corona Remedies Limited IPO allotment status on the registrar website — Link Intime India Pvt Ltd (https://linkintime.co.in). You can also check on BSE (bseindia.com → Investors → Application Status) using your PAN number. Allotment is finalised on 14 February 2026.
Is Corona Remedies Limited IPO good for investment?
IPOGenie rates Corona Remedies Limited IPO as "Subscribe" with a score of 84/100. Ahmedabad-based pharma company manufacturing branded generic formulations in cardiovascular, anti-diabetic, GI, and respiratory segments. 3 WHO-GMP ce... Always read the RHP and consult a SEBI-registered advisor before investing.
How to apply for Corona Remedies Limited IPO?
Apply for Corona Remedies Limited IPO through: (1) UPI method — use any broker app (Zerodha, Groww, Upstox) and approve the UPI mandate. (2) ASBA — through your bank's net banking IPO section. Apply at cut-off price for best allotment odds. Maximum retail application is ₹2 lakh (13 lots).
What is the issue size of Corona Remedies Limited IPO?
Corona Remedies Limited IPO total issue size is ₹3840 Cr. Fresh issue is ₹1200 Cr and Offer for Sale (OFS) is ₹2640 Cr. Anchor investor allocation was ₹1152 Cr.